Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

MRKR

Marker Therapeutics (MRKR)

Marker Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRKR
DateTimeSourceHeadlineSymbolCompany
03/18/20214:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
03/18/20214:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
03/16/20214:57PMPR Newswire (US)Marker Therapeutics, Inc. Announces Closing of Public Offering of Common StockNASDAQ:MRKRMarker Therapeutics Inc
03/15/20214:45PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MRKRMarker Therapeutics Inc
03/15/20217:00AMPR Newswire (US)Marker Therapeutics to Present at the Virtual Oppenheimer 31st Annual Healthcare ConferenceNASDAQ:MRKRMarker Therapeutics Inc
03/12/20218:00AMPR Newswire (US)Marker Therapeutics, Inc. Announces Pricing of Public Offering of Common StockNASDAQ:MRKRMarker Therapeutics Inc
03/11/20214:10PMPR Newswire (US)Marker Therapeutics, Inc. Announces Proposed Public Offering of Common StockNASDAQ:MRKRMarker Therapeutics Inc
03/11/20214:07PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MRKRMarker Therapeutics Inc
03/09/20214:48PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:MRKRMarker Therapeutics Inc
03/09/20214:37PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
03/09/20214:12PMPR Newswire (US)Marker Therapeutics Reports Fiscal Year 2020 Operating and Financial ResultsNASDAQ:MRKRMarker Therapeutics Inc
03/03/20217:41AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
03/03/20217:00AMPR Newswire (US)Marker Therapeutics Announces Dosing of First Patient in Phase 2 Trial of MT-401 in Acute Myeloid Leukemia Following Stem Cel...NASDAQ:MRKRMarker Therapeutics Inc
02/24/202111:43AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:16PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:14PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:07PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20216:00PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:MRKRMarker Therapeutics Inc
02/12/20215:59PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:MRKRMarker Therapeutics Inc
01/13/20217:43AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
01/13/20217:00AMPR Newswire (US)Marker Therapeutics Announces Completion of New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T...NASDAQ:MRKRMarker Therapeutics Inc
01/05/20214:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MRKRMarker Therapeutics Inc
01/05/20217:00AMPR Newswire (US)Marker Therapeutics Announces FDA Lifted Partial Clinical Hold on Phase 2 AML Clinical TrialNASDAQ:MRKRMarker Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MRKR